Primary diffuse cutaneous plasmacytoma: when a correct clinico-pathologic approach is mandatory for the patient's health☆☆☆
Sign Up to like & getrecommendations! Published in 2019 at "Anais Brasileiros de Dermatologia"
DOI: 10.1016/j.abd.2019.04.004
Abstract: De Capitani EM, Vieira RJ, Bucaretchi F, Fernandes LC, Toledo AS, Camargo AC. Human accidents involving Rhinocricus spp., a common millipede genus observed in urban areas of Brazil. Clin Toxicol (Phila). 2011;49:187--90. Haddad V Jr,… read more here.
Keywords: cutaneous plasmacytoma; correct clinico; primary diffuse; diffuse cutaneous ... See more keywords
P152 Skin score trajectory associates with survival and pulmonary outcome in diffuse cutaneous systemic sclerosis
Sign Up to like & getrecommendations! Published in 2020 at "Rheumatology"
DOI: 10.1093/rheumatology/keaa111.147
Abstract: Skin thickness improves over time in most diffuse cutaneous systemic sclerosis (dcSSc) patients and the use of group level skin score (mRss) as an endpoint is clinical trials can be challenging. We explore the association… read more here.
Keywords: risk; mrss; skin; diffuse cutaneous ... See more keywords
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
Sign Up to like & getrecommendations! Published in 2021 at "Rheumatology"
DOI: 10.1093/rheumatology/keab604
Abstract: OBJECTIVES The aim of this study was to explore outcomes in a cohort of diffuse cutaneous systemic sclerosis (dcSSc) patients fulfilling eligibility criteria for stem cell transplantation (SCT) studies but receiving standard immunosuppression. METHODS From… read more here.
Keywords: cell transplantation; stem cell; diffuse cutaneous; systemic sclerosis ... See more keywords
Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan.
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1093/rheumatology/keac136
Abstract: OBJECTIVE To investigate outcomes following the tapering or discontinuation of tocilizumab in patients with diffuse cutaneous systemic sclerosis (dcSSc) in a real-world setting. METHODS Fifteen patients who were treated with tocilizumab for dcSSc were selected… read more here.
Keywords: systemic sclerosis; discontinuation tocilizumab; tocilizumab; diffuse cutaneous ... See more keywords
Newer therapeutic modalities for Actinomycetoma by Nocardia species
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Dermatology"
DOI: 10.1111/ijd.14073
Abstract: Invest Dermatol 2005; 124: 453–456. 14 Kolde G, Frosch PJ, Czarnetzki BM. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations. J Invest Dermatol 1984; 83: 175–178.… read more here.
Keywords: urticaria pigmentosa; newer therapeutic; cutaneous mastocytosis; diffuse cutaneous ... See more keywords
AB0003 A mif promoter polymorphism is associated with the susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis patients
Sign Up to like & getrecommendations! Published in 2017 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-eular.1907
Abstract: Background Systemic sclerosis (SSc) is a fibrotic immune-mediated disease of unknown etiology. Among its clinical manifestations, pulmonary involvement is the leading cause of mortality in SSc patients. However, the genetic factors involved in lung complication… read more here.
Keywords: mif promoter; ssc; pulmonary arterial; systemic sclerosis ... See more keywords
A Phase II randomised controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).
Sign Up to like & getrecommendations! Published in 2022 at "Rheumatology"
DOI: 10.1136/annrheumdis-2022-eular.694
Abstract: OBJECTIVES Although the painful and disabling features of early diffuse cutaneous systemic sclerosis (dcSSc) have an inflammatory basis and could respond to corticosteroids, corticosteroids are a risk factor for scleroderma renal crisis. Whether or not… read more here.
Keywords: prednisolone; systemic sclerosis; trial; diffuse cutaneous ... See more keywords
Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Scleroderma and Related Disorders"
DOI: 10.1177/23971983211043311
Abstract: The aim of this study was to identify and prioritize aspects essential for decision making in patients with diffuse cutaneous systemic sclerosis (dcSSc) and to gain insight into information preferences of treatment options which could… read more here.
Keywords: information; treatment options; treatment; consensus ... See more keywords
Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review
Sign Up to like & getrecommendations! Published in 2023 at "Medicina"
DOI: 10.3390/medicina59020247
Abstract: Scleroderma or systemic sclerosis (SSc) is an autoimmune disease affecting the connective tissue, characterized by fibrosis of the skin and internal organs. There is currently no curative treatment available, so therapeutic action is aimed at… read more here.
Keywords: systemic sclerosis; review; biological drugs; diffuse cutaneous ... See more keywords